Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Residual Tumor”

768 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 768 results

Testing effectiveness (Phase 2)Looking for participantsNCT05023018
What this trial is testing

NEO100 and High-Grade Meningioma

Who this might be right for
Residual, Progressive or Recurrent Grade II or III Meningioma
Neonc Technologies, Inc. 30
Not applicableUnknownNCT06151691
What this trial is testing

Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 51
Large-scale testing (Phase 3)Looking for participantsNCT05623267
What this trial is testing

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Who this might be right for
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University 346
Not applicableUnknownNCT03255395
What this trial is testing

Focused Ultrasound Treatment of Stump Neuromas for the Relief of Chronic Post-Amputation Neuropathic Pain

Who this might be right for
Phantom Limb PainResidual LimbsAmputation
Rambam Health Care Campus 10
Early research (Phase 1)Study completedNCT03473639
What this trial is testing

A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy

Who this might be right for
Metastatic Breast CancerBreast Cancer
University of Virginia 13
Testing effectiveness (Phase 2)Ended earlyNCT00776100
What this trial is testing

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 3
Testing effectiveness (Phase 2)UnknownNCT04982900
What this trial is testing

Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities

Who this might be right for
Multiple Primary Lung Cancers
Ruijin Hospital 138
Early research (Phase 1)Ended earlyNCT05001451
What this trial is testing

Study of GDX012 in Patients With MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
GammaDelta Therapeutics Limited 3
Not applicableLooking for participantsNCT06514118
What this trial is testing

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

Who this might be right for
Small-cell Lung CancerResidual TumorRadiation
Qingdao Central Hospital 70
Testing effectiveness (Phase 2)WithdrawnNCT01612910
What this trial is testing

Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

Who this might be right for
Breast Cancer Female
Barbara Ann Karmanos Cancer Institute
Not applicableUnknownNCT05873790
What this trial is testing

Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 30
Not applicableLooking for participantsNCT07214532
What this trial is testing

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement)
Natera, Inc. 725
Not applicableUnknownNCT04881812
What this trial is testing

Drug-Coated Balloon Coronary Angioplasty Versus Stenting for Treatment of Disease Adjacent to a Chronic Total Occlusion.

Who this might be right for
Chronic Total Occlusion of Coronary Artery
Amsterdam UMC, location VUmc 144
Not applicableActive Not RecruitingNCT04118192
What this trial is testing

NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer

Who this might be right for
Breast Cancer
University of Birmingham 72
Not applicableUnknownNCT05536700
What this trial is testing

Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 67
Not applicableActive Not RecruitingNCT05210283
What this trial is testing

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Exact Sciences Corporation 1,017
Not applicableLooking for participantsNCT01499394
What this trial is testing

Caris Biorepository Research Protocol

Who this might be right for
CancerEarly Detection of CancerMinimal Residual Disease
Caris Science, Inc. 100,000
Not applicableStudy completedNCT02339805
What this trial is testing

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

Who this might be right for
Non Hodgkin Lymphoma
Centre Henri Becquerel 30
Not applicableStudy completedNCT06826170
What this trial is testing

Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)

Who this might be right for
Pituitary NeoplasmsPituitary Adenoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 25
Not applicableEnded earlyNCT01770158
What this trial is testing

Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 8
Load More Results